文文 坡
讚了
$Ocugen(OCGN.US$
1. U.S. Phase 3 Bridging Study:
OCGN submitted an IND application to FDA on October 27, 2021, and FDA issued a Clinical Hold to OCGN on November 26, 2021. Currently, WE are waiting for the response from OCGN to FDA. The OCGN will receive a full response from the FDA on or after December 26, 2021. FDA will proceed with approval within 30 days of receiving OCGN's response.
1. U.S. Phase 3 Bridging Study:
OCGN submitted an IND application to FDA on October 27, 2021, and FDA issued a Clinical Hold to OCGN on November 26, 2021. Currently, WE are waiting for the response from OCGN to FDA. The OCGN will receive a full response from the FDA on or after December 26, 2021. FDA will proceed with approval within 30 days of receiving OCGN's response.
11
文文 坡
讚了
$Ardelyx(ARDX.US$ 短褲將其浸泡,可以遮蓋。只要保持在 1.45 以上,它將恢復至 1.75
已翻譯
22
61